Genetic Effects on miRNA Expression During Mid-Gestation Neocortical Development
Demographics (1)
- SEX - Biological sex as determined by genotype array and rna-sequencing XIST expression (phv00525903.v1.p1)
Reproductive Health (1)
- GESTATION_WEEK - Gestational age (phv00525907.v1.p1)
Other (27)
- ANALYTE_TYPE - Analyte type (phv00525910.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00525909.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00525902.v1.p1)
- DNAPurificationMethod - DNA purification method (phv00525928.v1.p1)
- FILETYPE - File type (phv00525913.v1.p1)
- GenotypePlatform - DNA genotype platform (phv00525929.v1.p1)
- HISTOLOGICAL_TYPE - Tissue type (phv00525912.v1.p1)
- IS_TUMOR - Tumor status (phv00525911.v1.p1)
- Lanes - RNA sequencing lane (phv00525921.v1.p1)
- Pool - RNA sequencing pool (phv00525920.v1.p1)
- ReadsPerSample - RNA reads per sample (phv00525922.v1.p1)
- RIN - ERIN score (phv00525923.v1.p1)
- RNA_260_230 - RNA 260 absorbance over 230 absorbance (phv00525924.v1.p1)
- RNA_260_280 - RNA 260 absorbance over 280 absorbance (phv00525925.v1.p1)
- RNAConcentration - RNA concentration (phv00525926.v1.p1)
- RNALibraryKit - RNA library kit (phv00525915.v1.p1)
- RNALibraryType - RNA library type (phv00525914.v1.p1)
- RNAPurificationMethod - RNA purification method (phv00525927.v1.p1)
- SAMPLE_ID - Sample ID (phv00525908.v1.p1)
- SAMPLE_ID - Sample ID (phv00525905.v1.p1)
- SequencingDate - RNA sequencing date (phv00525917.v1.p1)
- SequencingProject - RNA sequencing project (phv00525918.v1.p1)
- SequencingRun - RNA sequencing run (phv00525919.v1.p1)
- SUBJECT_ID - Subject ID (phv00525901.v1.p1)
- SUBJECT_ID - Subject ID (phv00525904.v1.p1)
- SUBJECT_ID - Subject ID (phv00525906.v1.p1)
- TruSeqBarcode - TruSeq RNA library barcode (phv00525916.v1.p1)